Search Results for

Clear All Filters

July 23, 2021 | American Prospect

Max Moran

Op-Ed

2020 Election/TransitionForeign PolicyRevolving Door

It's Big Business As Usual For Biden's Ambassadorship Picks

If Biden is emerging as an anti-monopoly president, then why is he rewarding Cohen, a fixer for one of the go-to examples of monopoly power in America? More importantly, if he hopes to redeem American democracy from Trumpism, why is Biden rewarding the political strategist for a company that does not care about basic voting rights, especially for Black people?

July 20, 2021

Dorothy Slater

Blog Post

2020 Election/TransitionClimateEthics in Government

FERC Nominee Must Be Independent From Utilities Driving Climate Crisis And Hurting Consumers

June 30th marked the last official day of Republican Neil Chatterjee’s term as a commissioner on the Federal Energy Regulatory Commission (FERC). Despite FERC’s obscurity, it is a critically important independent agency of the federal government that regulates the interstate transmission of oil, gas, and electricity, and reviews proposals to build gas terminals and pipelines. As of July 1st, a new commissioner nominated by President Biden and confirmed by the Senate could have stepped in, giving the five-seat board a Democratic majority. Biden has thus far failed to begin that process, so Chatterjee will remain serving an expired term until Biden appoints and the Senate confirms someone new.

July 13, 2021

Daniel Takash

Blog Post

2020 Election/TransitionIntellectual Property

GUEST CONTRIBUTION: What Can a New USPTO Director Do?

As of this writing, the Biden Administration has yet to announce a pick for director of the U.S. Patent and Trademark Office. As Fatou Ndiaye has pointed out, this is likely due to behind-the-scenes tension between patent hawks in the Democratic caucus, specifically Senator Chris Coons (D-DE), and the broader progressive, reformist forces in the administration that made it possible for the United States to back a waiver on obligations under the Trade-Related Aspects of Intellectual Property Rights.

May 17, 2021

Fatou Ndiaye

Blog Post

2020 Election/TransitionIntellectual PropertyPharma

Revolver Spotlight: Kevin Rhodes

When choosing the next PTO director, the Biden administration should rule out those who have a history of prioritizing profits and corporate interests over public health and safety. One such individual is Kevin Rhodes, an ally of Big Pharma who has vigorously defended efforts to keep drug prices high. His current employer, 3M, has abused its monopoly on the military earplug market to sell overpriced and faulty products to veterans. This should be immediately disqualifying for any future PTO director. Here are a few of the most alarming aspects of Kevin Rhodes’s career: